Clinical Trial

Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT07250152
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Myocardial Infarction (MI)
Enrollment 1,544 participants
Start Date 2025-12-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-26